Athanasios Fysikopoulos Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

7/2020	Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
1/2020	NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
11/2013	Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Athanasios Fysikopoulos Research Topics

Disease

4	Pulmonary Hypertension 01/2021 - 06/2014
4	Emphysema 01/2021 - 06/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 11/2013
1	Edema (Dropsy) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Hypoxia (Hypoxemia) 02/2018
1	Pulmonary Emphysema 11/2013

Drug/Important Bio-Agent (IBA)

4	SmokeIBA 01/2021 - 11/2013
3	Superoxides (Superoxide)IBA 01/2020 - 11/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 11/2013
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	NADPH Oxidase 2IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020
1	3-nitrotyrosineIBA 01/2020
1	AntioxidantsIBA 02/2018
1	mitoquinoneIBA 02/2018
1	Soluble Guanylyl CyclaseIBA 06/2014
1	AnionsIBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2013